Skip to main content
Northwestern University Feinberg School of Medicine

Precision Immunotherapy: Immunotherapy for Today and Tomorrow

2025 OncoSET Symposium

Register for April 25, 2025

On Friday, April 25th, the Lurie Cancer Center OncoSET program will hold it's annual symposium on new advances in precision medicine.  This year's theme is Immunotherapy for Today and Tomorrow.  We will look at novel immunotherapy strategies for solid tumors, immunotherapy biology, immunotherapy prediction markers, and management of immunotherapy toxicity.  Please join us for this informative and practical symposium.

Event Details

Participants attend the OncoSET symposium

Friday, April 25, 2025

8:00 a.m. - 9:00 a.m.
Registration, Exhibits & Breakfast

9:00 a.m. - 4:00 p.m.
Program

Agenda
Feinberg Pavilion

Northwestern Memorial Hospital

IN PERSON

Feinberg Pavilion, 3rd Floor Conference Center
251 E. Huron St., Chicago

Register

Keynote Speaker

Jaehyuk Choi
Jaehyuk Choi, MD, PhD
Northwestern University

Upcoming Immunotherapy Strategies

Confirmed Faculty

Bilal Anouti, MD
Northwestern University

Emanuelle Bellaguarda, MD
Northwestern University

Sunandana Chandra, MD, MS
Northwestern University

Jonathan Chen, MD, PhD
Northwestern University

Jennifer Choi, MD 
Northwestern University 

Lee Cooper, PhD 
Northwestern University

Vivek Narayan, MD, MS
University of Pennsylvania

Behtash Nezami, MD
Northwestern University

Daniel Olson, MD
University of Chicago

 

Conference Fees

Lurie Cancer Center Affiliate Rates
Affiliates include Northwestern University, Northwestern Medicine, Lurie Children's, Shirley Ryan AbilityLab, and Jesse Brown VA.
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $25
  Research Staff $25
  Faculty and/or Physician $50
General Rates
  Student, Fellow or Resident Complimentary
  Nurse or Allied Health Professional $50
  Research Staff $50
  Faculty and/or Physician $75
  Industry Representative $250

All participants must register in advance to receive connection information.

Conference Chair

David VanderWeele, MD, PhD
Northwestern University

Accreditation Information

Target Audience

This activity is intended for healthcare professionals involved in the treatment and care of patients with advanced or refractory cancers for whom precision medicine can help guide treatment choices. This includes medical, surgical, and radiation oncologists, pathologists, radiologists, other translational-oriented laboratory scientists, nurses, pharmacists, genetic counselors, and physician assistants.

Objectives

  1. Identify predictors of immunotherapy response
  2. Discuss biology of immunotherapy and upcoming immunotherapy strategies
  3. Apply prediction and management of immunotherapy toxicity for patients on therapy

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Surgery Continuous Certification Program

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. ABS CME credits will be submitted to the boards within 3 months of the conclusion of the activity.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus.

Additional Information

For additional information about the event, please contact us at cancer@northwestern.edu or 312-503-7809.

See also the OncoSET Precision Medicine webpage.